Sun Pharma to Acquire Organon in $11.75 Billion Deal, Shares Surge
Shares of Sun Pharmaceutical Industries climbed more than 7% on Monday after the company announced a major acquisition of U.S.-based
James David-Kings
April 27, 2026
